Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21562045 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis
Condition: Amyloidosis
Intervention: Drug: VELCADE

Indicates status has not been verified in more than two years